Coherus Biosciences (CHRS)
NASDAQ:CHRS

Coherus Biosciences (CHRS) Stock Investors

888 Followers
Based on 704,848 investor portfolios analyzed by TipRanks Open your own Smart Portfolio >

Average Holdings Size

0.8% of all portfolios hold CHRS
On average, investors allocate 2.34% of their portfolios to CHRS
The average holding size of this company in investors' portfolios.

Investor Sentiment

Currently, no data available
Please return soon. This page is being updated.
The overall sentiment of all investors covering this stock. Click on ‘Top Investors’ to focus on the best performers.

Portfolios Holding CHRS

0.9%
Last 7
Days
5.7%
Last 30
Days
Percentages indicate the change in the number of portfolios holding CHRS, out of 704,848 portfolios.
The average increase or decrease in average holding size of this stock in investor portfolios in the last 7 days or last 30 days.

CHRS Investor Activity

Investor Profile
Investor Action
Transaction Date
Portfolio Allocation
Execution Price
Follow
Opened
0.00%
$1.71
Opened
0.00%
$4.05
Increased
0.77%
$5.05
Reduced
0.00%
$5.42
Reduced
3.00%
$1.82
Opened
2.27%
$4.59
Opened
0.00%
$5.05
Opened
0.00%
$5.05
Opened
1.75%
$5.05
Opened
0.93%
$5.05
Based on the activity of 12,928 investors who made their portfolios public
The table shows changes in CHRS in the past 3 months by investors with public portfolios.
Investor activity updates every 24 hours.

CHRS Investors Also Bought

Name
Average Holding Size
Last 7D Change
Last 30D Change
Market Cap
Sector
3M Behavior
Follow
Micron
5.58%
+0.51%
-1.27%
85.11B
Technology
ChargePoint Holdings
3.88%
-0.04%
-0.66%
716.51M
Consumer Cyclical
Block
4.52%
+0.52%
+2.57%
37.04B
Technology
Snap
9.83%
-0.71%
-4.21%
20.88B
Communication Services
Marvell
4.83%
+0.27%
-1.24%
48.23B
Technology
Trade Desk
4.68%
+1.62%
+4.77%
33.92B
Technology
Salesforce
4.90%
+1.02%
-0.05%
218.72B
Technology
AMC Entertainment
5.32%
-0.26%
-2.77%
1.35B
Communication Services
Plug Power
4.59%
-0.07%
-1.46%
2.07B
Industrials
Merck & Company
4.28%
+0.67%
+0.47%
257.03B
Healthcare
Based on the activity of 704,848 active portfolios
Open your Smart Portfolio

CHRS Investor Analysis

CHRS investors under 35

Under 35

4.0%
Last 30 days
Holdings Change
14.6%
of CHRS holders
are under 35
Average Segment Performance
Average P/E Ratio19.24
Beta8.50
Dividend Yield7.32%
CHRS investors between 35–55

Between 35–55

5.9%
Last 30 days
Holdings Change
56.1%
of CHRS holders
are between 35–55
Average Segment Performance
Average P/E Ratio17.11
Beta12.65
Dividend Yield8.03%
CHRS investors over 55

Over 55

3.3%
Last 30 days
Holdings Change
29.2%
of CHRS holders
are over 55
Average Segment Performance
Average P/E Ratio15.73
Beta5.73
Dividend Yield7.66%
Overview of age group and performance of CHRS stock investors
See who invests in CHRS according to age group and performance.

FAQ

How many retail Investors hold CHRS?
0.8% of TipRank’s retail investors hold CHRS in their portfolios.
    What is CHRS Investor Sentiment?
    CHRS’s Investor Sentiment is Very Negative.
      What percentage of retail investors changed their holding of CHRS in the last 7 days?
      ▼ 0.9% of TipRank’s retail investors changed their holding of CHRS in the last 7 days.
        What percentage of retail investors changed their holding of CHRS in the last 30 days?
        ▼ 5.7% of TipRank’s retail investors changed their holding of CHRS in the last 30 days.
          What is the average age of retail investors who hold CHRS?
          The average age of CHRS Holders is between 35–55.
            What other stocks have CHRS investors also bought?
            CHRS Investors also bought MU, CHPT, SQ, SNAP, MRVL, TTD, CRM, AMC, PLUG, MRK.

              Stocks with the Most Positive Individual Investor Sentiment in the Healthcare sector
              ACADACADIA Pharmaceuticals
              ALNYAlnylam Pharma
              CORCencora
              BDXBecton Dickinson
              BCRXBioCryst

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis